Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 122.50 billion as of August 15, 2025. Its market cap has decreased by -12.54% in one year.

Market Cap

122.50B

Enterprise Value

237.62B

Revenue

68.62B

Ranking

n/a

PE Ratio

n/a

Stock Price

620.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 122.50B, an increase of 3,751.36%. That is a compound annual growth rate of 13.11%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	122.50B	-6.34%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	524.12B	60.07%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.52T
Celltrion	38.58T
ALTEOGEN	23.35T
Yuhan	8,561.74B
Peptron	8,235.61B
SK Biopharmaceuticals	7,878.31B
PharmaResearch	7,106.52B
LigaChem Biosciences	5,666.20B

Market Cap Rankings